Product Information
CEPHALEXIN 250 MG CAPSULE is a generic product labeled by Aurobindo Pharma Limited, priced at $0.0921 per EA under NDC 65862001801. Its NADAC has been published 665 times since Nov 28, 2013.
FDA first approved this application on Nov 16, 2005. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the Cephalexin market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
250 mg/1
Manufacturer
Aurobindo Pharma LimitedNDC
65862001801
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
CEPHALEXINApproval Type
Generic (ANDA)
FDA Application
ANDA065253FDA Approved
11/16/2005
TE Code
AB
On Market Since
11/16/2005
Pharmacological Classes
Price Statistics
The NADAC for CEPHALEXIN 250 MG CAPSULE has been published 665 times since Nov 28, 2013, and over the history we have for it it has declined 4.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0921 per EA |
|---|---|
| All-time high | $0.1171 (Feb 12, 2014) |
| All-time low | $0.0702 (Mar 22, 2017) |
| 52-week high | $0.1010 |
| 52-week low | $0.0921 |
| Median price | $0.0926 |
| Average price | $0.0919 |
| Largest weekly change | +28.4% (Aug 21, 2024) |
| Weeks tracked | 665 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 8 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of CEPHALEXIN 250 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for CEPHALEXIN 250 MG CAPSULE, manufactured by Aurobindo Pharma Limited, is $0.0921 per EA (NDC 65862001801), effective Aug 19, 2026.
How has the price of CEPHALEXIN 250 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for CEPHALEXIN 250 MG CAPSULE has declined 4.8%. It has been tracked across 665 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for CEPHALEXIN 250 MG CAPSULE?
Since Nov 28, 2013, the NADAC for CEPHALEXIN 250 MG CAPSULE has ranged from a low of $0.0702 (Mar 22, 2017) to a high of $0.1171 (Feb 12, 2014), with a median of $0.0926 per EA.
Are there cheaper alternatives to CEPHALEXIN 250 MG CAPSULE?
8 manufacturers publish a NADAC-priced product with the same active ingredient and strength as CEPHALEXIN 250 MG CAPSULE in a comparable dosage form, but none are currently priced below it.
Who manufactures CEPHALEXIN 250 MG CAPSULE?
CEPHALEXIN 250 MG CAPSULE (NDC 65862001801) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.